Stockscreener 앱 받기
9.62
0.31%
-0.03
시간 외 거래:
9.62
전일 마감가:
$9.65
열려 있는:
$9.74
하루 거래량:
48,298
Relative Volume:
1.18
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-11.66%
1개월 성능:
-12.35%
6개월 성능:
-11.34%
1년 성능:
-6.78%
1일 변동 폭
$9.55
$9.74
1주일 범위
$9.55
$10.84
52주 변동 폭
$9.55
$12.53
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| GNOM | 9.62 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 291.49 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 588.15 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 591.11 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 247.33 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 500.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf 주식(GNOM)의 최신 뉴스
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Top Canadian Genetics Stocks of 2024 - The Motley Fool Canada
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
(GNOM) Proactive Strategies - Stock Traders Daily
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Time for Healthcare ETFs? - Yahoo Finance
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
7 Best Biotech ETFs to Buy Now | Investing - U.S News & World Report Money
How To Trade (GNOM) - Stock Traders Daily
Top Sector ETFs From Wall Street's Best Week in 3 Months - Yahoo New Zealand News
Why this money manager is shoring up cash and buying into commodities, genomics and Mexico - The Globe and Mail
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
When the Price of (GNOM) Talks, People Listen - Stock Traders Daily
Where are the Opportunities in (GNOM) - Stock Traders Daily
Private Advisor Group LLC Lowers Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
9 Best Biotech ETFs for 2024 - MSN
Beyond Ordinary Model Portfolios - Global X
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 69.1% - Defense World
Profit from the Genomics Market Momentum With These ETFs - Yahoo Movies UK
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - InvestorPlace
Genomics ETF (GNOM) Hits New 52-Week High - Yahoo Lifestyle UK
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
(GNOM) Technical Data - Stock Traders Daily
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
Genomics and the Future of Healthcare Diagnostics – Global X ETFs - Global X
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Biotech Funds Underperform the Broader Market - Trackinsight
Video: Give Someone a Fish, You Feed Them—Unlock the Fish - CSRwire.com
Gene Therapy: A Cure for Cancer? - Opto RoW
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 ... - Nature.com
The Next Big Theme: February 2024 – Global X ETFs - Global X
Genomic data in the All of Us Research Program - Nature.com
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
Two industries where Einstein would invest - Finimize
3 Biotech ETFs to Bet on Now - Nasdaq
Global X Genomics Biotechnology Etf (GNOM) 재무 분석
Global X Genomics Biotechnology Etf (GNOM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.46%
자본화:
|
볼륨(24시간):